Stepan (SCL) to Release Quarterly Earnings on Tuesday

Stepan (NYSE:SCL) will be issuing its quarterly earnings data before the market opens on Tuesday, April 24th. Analysts expect the company to announce earnings of $1.29 per share for the quarter.

Stepan (NYSE:SCL) last announced its quarterly earnings data on Thursday, February 22nd. The basic materials company reported $1.06 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.67 by $0.39. The company had revenue of $473.82 million during the quarter, compared to the consensus estimate of $457.95 million. Stepan had a return on equity of 15.20% and a net margin of 4.76%. The firm’s revenue was up 12.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.52 EPS. On average, analysts expect Stepan to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

How to Become a New Pot Stock Millionaire

Shares of NYSE:SCL opened at $87.62 on Tuesday. The company has a market cap of $1,935.31, a P/E ratio of 18.84 and a beta of 1.09. The company has a quick ratio of 1.92, a current ratio of 2.46 and a debt-to-equity ratio of 0.36. Stepan has a 12-month low of $68.75 and a 12-month high of $92.97.

In related news, VP Frank Pacholec sold 6,000 shares of the business’s stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $86.52, for a total value of $519,120.00. Following the transaction, the vice president now directly owns 40,120 shares of the company’s stock, valued at approximately $3,471,182.40. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Gregory Servatius sold 2,479 shares of the business’s stock in a transaction that occurred on Wednesday, March 7th. The stock was sold at an average price of $85.22, for a total value of $211,260.38. Following the completion of the transaction, the vice president now directly owns 48,620 shares in the company, valued at $4,143,396.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 48,023 shares of company stock worth $3,958,109. 12.60% of the stock is owned by insiders.

SCL has been the subject of a number of recent research reports. Zacks Investment Research upgraded Stepan from a “sell” rating to a “hold” rating in a research note on Wednesday, February 28th. ValuEngine upgraded Stepan from a “hold” rating to a “buy” rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $35.60.

TRADEMARK VIOLATION NOTICE: “Stepan (SCL) to Release Quarterly Earnings on Tuesday” was first reported by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://weekherald.com/2018/04/17/stepan-scl-to-release-quarterly-earnings-on-tuesday.html.

About Stepan

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. The company operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, and lubricating ingredients.

Earnings History for Stepan (NYSE:SCL)

Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply